Your browser doesn't support javascript.
loading
First-line chemotherapy or in combination with programmed cell death protein-1 antibody in patients with metastatic or recurrent biliary tract cancer.
Zhao, Shu; Guo, Xue-Guang; Zhang, Dong; Zhou, Gang; Song, Peng; Yang, Jing; Zhang, Yong; Li, Peng; Hu, Yi; Wang, Peng.
Afiliação
  • Zhao S; Department of Medical Oncology, The Second Medical Centre and National Clinical Research Center for Geriatric Diseases, Chinese People's Liberation Army General Hospital, Beijing, China.
  • Guo XG; Department of Medical Oncology, The Second Medical Centre and National Clinical Research Center for Geriatric Diseases, Chinese People's Liberation Army General Hospital, Beijing, China.
  • Zhang D; Department of Medical Oncology, The Second Medical Centre and National Clinical Research Center for Geriatric Diseases, Chinese People's Liberation Army General Hospital, Beijing, China.
  • Zhou G; Department of Medical Oncology, The Second Medical Centre and National Clinical Research Center for Geriatric Diseases, Chinese People's Liberation Army General Hospital, Beijing, China.
  • Song P; Department of Medical Oncology, The Second Medical Centre and National Clinical Research Center for Geriatric Diseases, Chinese People's Liberation Army General Hospital, Beijing, China.
  • Yang J; Department of Medical Oncology, The Second Medical Centre and National Clinical Research Center for Geriatric Diseases, Chinese People's Liberation Army General Hospital, Beijing, China.
  • Zhang Y; Department of Medical Oncology, The Second Medical Centre and National Clinical Research Center for Geriatric Diseases, Chinese People's Liberation Army General Hospital, Beijing, China.
  • Li P; Department of Medical Oncology, The Second Medical Centre and National Clinical Research Center for Geriatric Diseases, Chinese People's Liberation Army General Hospital, Beijing, China.
  • Hu Y; Department of Medical Oncology, The Fifth Medical Centre, Chinese People's Liberation Army General Hospital, Beijing, China.
  • Wang P; Department of Medical Oncology, The Second Medical Centre and National Clinical Research Center for Geriatric Diseases, Chinese People's Liberation Army General Hospital, Beijing, China.
J Gastroenterol Hepatol ; 36(12): 3541-3547, 2021 Dec.
Article em En | MEDLINE | ID: mdl-34423859
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Biliar / Recidiva Local de Neoplasia Limite: Humans Idioma: En Revista: J Gastroenterol Hepatol Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Biliar / Recidiva Local de Neoplasia Limite: Humans Idioma: En Revista: J Gastroenterol Hepatol Ano de publicação: 2021 Tipo de documento: Article